"N Engl J Med"[journal] 检索结果

41. The Inequality-Pandemic Cycle - Rethinking Preparedness.

作者: Matthew M Kavanagh.;Joseph E Stiglitz.;Monica Geingos.;Winnie Byanyima.;Michael G Marmot.; .
来源: N Engl J Med. 2026年395卷6期521-524页

42. iEvac-Z, an Inactivated Ebola Vaccine - Phase 1 Study in Japan.

作者: Tokiko Watanabe.;Michiko Koga.;Masanori Nojima.;Minako Kono.;Yuriko Tomita.;Tadashi Maemura.;Itsuki Anzai.;Yuri Furusawa.;Calvin Duong.;Yoichiro Kino.;Peter J Halfmann.;Fumitaka Nagamura.;Hiroshi Yotsuyanagi.;Yoshihiro Kawaoka.
来源: N Engl J Med. 2026年395卷7期715-717页

43. Pregnancies in Patients with Autoimmune Disease Receiving CAR T-Cell Therapy.

作者: Georg Schett.;Andreas Wirsching.;Tobias Rothe.;Vanessa Visconti.;Neil Kramer.;Markus Metzler.;Tobias Krickau.;Gregory W Kirschen.;Daphne Landau.;Caitlin Elgarten.;Vikas Majithia.;Ellen De Langhe.;Peter Vandenberghe.;Britta Maurer.;Zahir Amoura.;David Simon.;Gerhard Krönke.;Peter Gergely.;Melissa Fernandes.;Tamas Shisha.;Brandon M Law.;Ashley Koegel.;David J Chang.;Andreas Mackensen.;Fabian Müller.;Melanie Hagen.
来源: N Engl J Med. 2026年

44. Sex Hormone Influences on Cardiovascular Risk. Reply.

作者: Leslie Skeith.;Shannon M Bates.
来源: N Engl J Med. 2026年395卷5期

45. Sex Hormone Influences on Cardiovascular Risk.

作者: Fabrice Bonnet.;Patricia Vaduva.
来源: N Engl J Med. 2026年395卷5期519-520页

46. Sex Hormone Influences on Cardiovascular Risk.

作者: Jonathan Douxfils.;Mitchell D Creinin.;Jean-Michel Foidart.
来源: N Engl J Med. 2026年395卷5期518-519页

47. Transdermal Estradiol Patches in Prostate Cancer. Reply.

作者: Ruth E Langley.;Duncan C Gilbert.;Matthew Nankivell.
来源: N Engl J Med. 2026年395卷5期517-518页

48. Transdermal Estradiol Patches in Prostate Cancer.

作者: Mathis Grossmann.;Nicholas Russell.
来源: N Engl J Med. 2026年395卷5期517页

49. Transdermal Estradiol Patches in Prostate Cancer.

作者: Carly Sears.;Larry Schuller.
来源: N Engl J Med. 2026年395卷5期517页

50. LDL Cholesterol Targeting in Cardiovascular Disease. Reply.

作者: Yong-Joon Lee.;Byeong-Keuk Kim.
来源: N Engl J Med. 2026年395卷5期516页

51. LDL Cholesterol Targeting in Cardiovascular Disease.

作者: Paolo Cravedi.;Piero Luigi Ruggenenti.;Giuseppe Remuzzi.
来源: N Engl J Med. 2026年395卷5期515-516页

52. LDL Cholesterol Targeting in Cardiovascular Disease.

作者: Qingqing Zhu.;Sibo Wang.
来源: N Engl J Med. 2026年395卷5期515页

53. LDL Cholesterol Targeting in Cardiovascular Disease.

作者: Daan J L van Twist.;Jay Beeren.
来源: N Engl J Med. 2026年395卷5期514-515页

54. LDL Cholesterol Targeting in Cardiovascular Disease.

作者: Richard R Howell.;Kelly W Jones.
来源: N Engl J Med. 2026年395卷5期514页

55. LDL Cholesterol Targeting in Cardiovascular Disease.

作者: Jaya Mallidi.;Amir Lotif.
来源: N Engl J Med. 2026年395卷5期513-514页

56. T-Cell Engager-Mediated HLA Antibody Depletion before Kidney Transplantation.

作者: Martina Schatzl.;Katharina A Mayer.;Hermine Agis.;Susanne Haindl.;Daniela Kriks.;Gottfried Fischer.;Markus Exner.;Gideon Hönger.;Nikolina Veljancic.;Daniela M Allmer.;Irene Graf.;Matthias Diebold.;Philip F Halloran.;Anne Halpin.;Caishun Li.;Lori West.;Nicolas Kozakowski.;Georg A Böhmig.
来源: N Engl J Med. 2026年395卷5期511-513页

57. Cross-Correction in HSC Gene Therapy for Metachromatic Leukodystrophy.

作者: Vasco Meneghini.;Valeria Calbi.;Filippo Casalini.;Elisabeth Mangiameli.;Francesco Morena.;Marco Piccoli.;Ilaria Laface.;Ilaria Rossomanno.;Francesca Ornaghi.;Andrea Ghiroldi.;Paola M V Rancoita.;Francesca Fumagalli.;Sabata Martino.;Luigi Anastasia.;Luigi Naldini.;Alessandro Aiuti.;Angela Gritti.
来源: N Engl J Med. 2026年395卷5期508-511页

58. Case 22-2026: A 37-Year-Old Woman with Persistent Nasal Ulceration.

作者: Stacey T Gray.;Carolina D Geadas.;Peter M Sadow.
来源: N Engl J Med. 2026年395卷5期493-501页

59. Milwaukee Shoulder Syndrome.

作者: John Woller.;Ayse Z Ulger.
来源: N Engl J Med. 2026年395卷5期492页

60. Phase 2b Trial of a NaV1.8 Inhibitor for Acute Pain.

作者: Neil Singla.;Nathaniel P Katz.;Ben Vaughn.;Timothy Rogier.;Todd Bertoch.;Harold Minkowitz.;Mallory Loflin.
来源: N Engl J Med. 2026年395卷5期454-464页

Nav1.8, a voltage-gated sodium channel expressed in the peripheral nervous system, has a critical role in pain signaling. Previous trials of NaV1.8 inhibitors have shown effectiveness in reducing postoperative pain.

结果排序

文献格式

出版时间

出版类型

出版语言